Results 11 to 20 of about 10,851,050 (358)

CAR-T cell combination therapy: the next revolution in cancer treatment

open access: yesCancer Cell International, 2022
In recent decades, the advent of immune-based therapies, most notably Chimeric antigen receptor (CAR)-T cell therapy has revolutionized cancer treatment.
Maysoon Al-Haideri   +10 more
semanticscholar   +1 more source

Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future

open access: yesBioengineering, 2022
As a safe and minimal-invasive modality, thermal therapy has become an effective treatment in cancer treatment. Other than killing the tumor cells or destroying the tumor entirely, the thermal modality results in profound molecular, cellular and ...
Qizheng Dai   +3 more
doaj   +1 more source

Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.

open access: yesNew England Journal of Medicine, 2021
BACKGROUND Uterine fibroids are a common cause of heavy menstrual bleeding and pain. Treatment with the combination of relugolix (an oral gonadotropin-releasing hormone-receptor antagonist), estradiol, and norethindrone acetate, administered once daily ...
A. Al-Hendy   +11 more
semanticscholar   +1 more source

Drug combination therapy for emerging viral diseases

open access: yesDrug Discovery Today, 2021
Effective therapeutics to combat emerging viral infections are an unmet need. Historically, treatments for chronic viral infections with single drugs have not been successful, as exemplified by human immunodeficiency virus (HIV) and hepatitis C virus ...
Zeenat A. Shyr   +3 more
semanticscholar   +1 more source

Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension: A Systematic Review and Meta-Analysis.

open access: yesHYPERTENSION, 2021
Poor adherence to antihypertensive therapy is a major cause of poor blood pressure (BP) control in patients with hypertension. Regimen simplification may improve adherence and BP control.
G. Parati   +4 more
semanticscholar   +1 more source

Targeted c-Myc Inhibition and Systemic Temozolomide Therapy Extend Survival in Glioblastoma Xenografts

open access: yesBioengineering, 2023
Glioblastoma is a highly aggressive disease with poor patient outcomes despite current treatment options, which consist of surgery, radiation, and chemotherapy.
Laxmi Dhungel   +4 more
doaj   +1 more source

Combination therapy for cough and bronchial obstruction in childhood

open access: yesМедицинский совет, 2019
The inflammatory process in the bronchial mucosa of various origins (infectious, allergic, irritative, etc.) cause changes in the sputum production and its rheological properties, slowing of mucociliary clearance.
Yu. L. Mizernitskiy   +2 more
doaj   +1 more source

Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program

open access: yesРоссийский кардиологический журнал, 2021
Aim. In practice, to evaluate the efficacy, safety and long-term adherence to therapy with a fixed-dose combination of ramipril/indapamide (Konsilar-D24) in patients with grade 1-2 hypertension (HTN) who have not achieved blood pressure (BP) control with
A. O. Konradi   +9 more
doaj   +1 more source

Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics

open access: yesBiology, 2021
Simple Summary Vincristine is a vinca alkaloid naturally occurring in Catharanthus roseus. It belongs to antimitotic compounds, which arrest the cell cycle via disrupting microtubule dynamics.
Jan Škubník   +3 more
semanticscholar   +1 more source

Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft (PDOX) mouse model. [PDF]

open access: yes, 2017
An excessive requirement for methionine termed methionine dependence, appears to be a general metabolic defect in cancer. We have previously shown that cancer-cell growth can be selectively arrested by methionine deprivation such as with recombinant ...
Chmielowski, Bartosz   +15 more
core   +2 more sources

Home - About - Disclaimer - Privacy